Evidence map›Paper›PMID 40131964›Full record

Observational studyPloS one2025

Clinical characteristics, antimicrobial resistance, and mortality of neonatal bloodstream infections in Northern Tanzania, 2022-2023.

Ganga S Moorthy, Matthew P Rubach, Anna Sechu, Ronald Mbwasi, Nyemo Peter, Ibukunoluwa C Kalu, John A Crump, Dorothy E Dow, Blandina T Mmbaga, Aisa Shayo

Abstract readObservational Study
In one paragraph

Observational study in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ganga S MoorthyDivision of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America.ORCID https://orcid.org/0000-0003-3191-1117
Matthew P RubachDuke Global Health Institute, Duke University, Durham, North Carolina, United States of America.
Anna SechuKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Ronald MbwasiKilimanjaro Christian Medical University College, Tumaini University, Moshi, Tanzania.ORCID https://orcid.org/0000-0002-2365-5072
Nyemo PeterKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Ibukunoluwa C KaluDivision of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America.
John A CrumpDuke Global Health Institute, Duke University, Durham, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-4529-102X
Dorothy E DowDivision of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America.
Blandina T MmbagaDuke Global Health Institute, Duke University, Durham, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-5550-1916
Aisa ShayoKilimanjaro Christian Medical University College, Tumaini University, Moshi, Tanzania.ORCID https://orcid.org/0000-0002-3321-9055

Funding

Partnership for Global Health Research Training Program (Renewal)-Supplement for OBSSR, NCI, NCI-AIDS and NIDCDD43TW010543 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Wafaie W Fawzi, DAVIDSON HOWES HAMER · 2017 to 2026
$12.1M
Unified Program for Therapeutics in Children (UPTiC)T32HD094671 · NICHD · DUKE UNIVERSITY · PI Ian J Davis, Kanecia Obie Zimmerman · 2019 to 2026
$2.9M
Investigating Febrile Deaths in Tanzania (INDITe)R01AI121378 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$2.7M
FIC NIH HHS D43 TW010543NIAID NIH HHS R01 AI121378NICHD NIH HHS T32 HD094671
6 · The paper itself

Abstract

Neonatal bloodstream infections (BSI) make a substantial contribution to morbidity and mortality in low- and middle-income countries (LMICs), but data on the epidemiology and antimicrobial resistance (AMR) in Tanzania are limited. We describe the prevalence, resistance patterns, and associated factors of neonatal BSI at the Kilimanjaro Christian Medical Centre (KCMC), a large referral hospital in northern Tanzania. We conducted a prospective, observational study involving infants aged 0-60 days with perinatal risk factors or clinical signs of sepsis. Aerobic blood cultures were obtained at enrollment and monitored using a continuously monitored blood culture instrument. Antimicrobial susceptibility testing was performed using standard phenotypic methods. Vital status was obtained on days 2, 7, and 28 post-enrollment. BSI was defined as the isolation of established neonatal pathogens, including yeast and coagulase-negative Staphylococcus spp. (CoNS). Early-onset BSI occurred on day of life (DOL) 0-2, while late-onset BSI occurred on DOL 3 or later. Among 236 enrolled infants, blood culture was obtained in 233. BSI occurred in 106 (45.5%) of 233 infants, 50 (47.2%) were early-onset, and 56 (52.8%) were late-onset BSI. The isolated pathogens included 58 (54.7%) Gram-positive bacteria, 40 (37.7%) Gram-negative bacteria, and 8 (7.5%) yeast. CoNS (n = 55, 51.9%) and Klebsiella pneumoniae (n = 35, 33.0%) were the most common pathogens. Notably, all K. pneumoniae isolates were extended-spectrum beta-lactamase producers, resistant to ampicillin and ceftriaxone. Among the 56 infants who died, 29 (51.8%) had BSI; 11 (19.6%) infants with EO-BSI, and 18 (32.1%) with LO-BSI. Infants requiring respiratory support at admission had a 1.89-fold increased adjusted odds of BSI (95% CI, 1.05-3.44). We found high prevalence of neonatal BSI due to bacteria with a high prevalence of AMR, and BSI was associated with high mortality. There is an urgent need for effective preventive, diagnostic, and therapeutic interventions to address BSI among hospitalized infants in northern Tanzania.

Indexed as

Anti-Bacterial AgentsBacteremiaDrug Resistance, BacterialNeonatal SepsisFemaleHumansInfantInfant, NewbornMaleMicrobial Sensitivity TestsPrevalenceProspective StudiesTanzaniaAnti-Bacterial Agents

Identifiers

PMID40131964
PMCPMC11936297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.